PuRPOSE programme I: Multinational collaborative research started with Samsung Medical Center and 4 Singapore institutions (Institute of Molecular and Cell Biology, Genome Institute of Singapore, National Cancer Center Singapore, National University of Singapore)
August
AIMEDBIO founded in Korea as a spin-off company of Samsung Medical Center
2019
June
Started collaboration with CBmed, European Biobank
August
AVATAMED PTE LTD founded in Singapore
November
Technology transferred from PuRPOSE programme (A*STAR, NUS, NCCS, Samsung Medical Center)
2020
January
Joined COMET project
March
Seed Investment Technology transferred from AIMEDBIO
August
Avata Healthcare launched
November
Started collaboration with Macrogen, leading company in precision medicine and biotechnology
